AB Science presents masitinib Phase 2B/3 MS study results at ACTRIMS-ECTRIMS
The ACTRIMS-ECTRIMS international conference, originally planned to take place in Washington, DC, was held virtually between the 11th and 13th of September due to restrictions caused by the ongoing COVID-19 pandemic. The event is held every three years and represents a meeting of the best minds in terms of medical and scientific expertise, innovation, and…
